{"id":562268,"date":"2021-09-09T12:16:01","date_gmt":"2021-09-09T12:16:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=562268"},"modified":"2021-09-09T12:16:01","modified_gmt":"2021-09-09T12:16:01","slug":"pompe-disease-epidemiology-forecast-report-2030-pompe-disease-epidemiology-analysis-2030-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/pompe-disease-epidemiology-forecast-report-2030-pompe-disease-epidemiology-analysis-2030-delveinsight_562268.html","title":{"rendered":"Pompe Disease Epidemiology Forecast Report 2030 | Pompe Disease Epidemiology Analysis 2030 | DelveInsight"},"content":{"rendered":"
\n
\"Pompe<\/a><\/div>\n
\n
DelveInsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
DelveInsight\u2019s \u2018Pompe Disease (PD) – Epidemiology Forecast to 2030\u2019 report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Pompe Disease in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.<\/div>\n

DelveInsight launched a new report on Pompe Disease Epidemiology Forecast, 2030.<\/a><\/strong><\/p>\n

Pompe disease is a rare genetic disease characterized by the abnormal buildup of a sugar molecule called glycogen inside cells. This buildup impairs the working of different organs and tissues, especially the heart, respiratory, and skeletal muscles.<\/p>\n

DelveInsight’s ‘Pompe Disease Epidemiology Forecast to 2030<\/strong><\/a>‘ report delivers an in-depth understanding of the disease, historical and forecasted Pompe Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.<\/p>\n

\"\"<\/p>\n

Some of the key highlights from the Pompe Disease Epidemiology Report:<\/strong><\/p>\n